All Type of News


Pharmas get huge impacts if being careless on ‘Financial Gain and Expenditure Report’

While the ‘Financial Gain and Expenditure Report’ will be implemented January next year, pharmaceutical companies were criticized to have thorough preparations. This is because they might get in a huge trouble as jud...

23 Korean potential biotech companies will gather in event

The Korea Biotechnology Industry Organization(President Jeong-Sun Seo, KoreaBIO) will hold a biotech pipeline investor forum jointly with Mirae Asset Daewoo for a week from the 13th at the Mirae Asset Daewoo headquart...

Korea’s health care quality improved, but use of quinolone antibiotics is higher than OECD average

The Korean health care quality including outpatient prescription has been reportedly enhanced overall, but the management of chronic diseases was diagnosed that it needed improvements. The Organisation for Economic C...

Only did 1 of 10 seniors have experience in hearing about generic substitution from pharmacists

Since it was only 1 of 10 seniors who were guided generic substitution, it was reported it needed to strengthen the consumers’ right to choose medicines. According to the ‘Senior Consumer Right Strengthening Plan(Med...

Ilyang Pharmaceutical’s ‘Supect’ effectively inhibits Parkinson’s disease progress

The preclinical and efficacy result on the Ilyang Pharmaceutical’s(President Dong-Yeon Kim) chronic myelocytic leukemia treatment ‘Supect(generic name: radotinib)’ for Parkinson’s disease(PD) was announced at the ‘Ame...

Vemlidy’s active competition in chronic hepatitis B treatment market

Gilead Sciences’ ‘Vemlidy Tab’ has entered general hospitals one after another, which raises an expectation on its sales performance in the future. ‘Vemlidy,’ a Gilead Sciences’ chronic hepatitis B treatment whose he...

“Government must let the medical field know of ways to guarantee profits from the coverage extension plan”

“The government has no choice but to give a higher price than product cost for the medical industry in the process of making a drug insured. People need to know of this.” Yong-Ik Kim, a former The Minjoo Party repres...

Hanmi Pharm’s Olita available for insurance benefits from coming 15th

The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) announced the ‘Drug Insurance Benefits List and Upper Limit Price Table’ had been revised and the Hanmi Pharm’s targeted therapy for non-small cell lun...

Seoul and Busan, Ulsan & Gyeonggi Pharmaceutical Associations moving towards invitation for their next chairman

The Seoul District Pharmaceutical Distribution Association and the Busan, Ulsan & Gyeongnam Pharmaceutical Distribution Association would choose their next chairman on their own. According to the industry concerned o...

Korean OTC drug instructions with low readability

Guideline and instructions written on OTC drugs that the Korean people use reportedly have low readability. Therefore, various improvements were suggested, such as better locations font sizes. The Dongguk University ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.